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Abstract
Background: Coronary arteriography is still widely accepted as a gold standard for the
diagnosis of coronary artery disease (CAD), despite emerging methods such as multi-slice
computed tomography. None of the presently available non-invasive diagnostic tests is perfect.
The aim of the article was to make a comparison of the value and limitations of history, resting
electrocardiography, exercise electrocardiography and dobutamine stress echocardiography in
the diagnosis of CAD, and to create a simple algorithm for non-invasive diagnosis of CAD to
optimize indications for coronarography.
Methods: Prospective, multicentre trial. The collection of clinical data, resting electrocardiography,
exercise treadmill electrocardiography, dobutamine stress echocardiography and catheteriza-
tion data was performed on 600 patients with chest pain regarded as angina pectoris and no
previous history of myocardial infarction. CAD was defined as ≥ 50% narrowing of at least
one major vessel. Final results were obtained in 551 patients, 65% male. The studied popula-
tion was divided into three groups on the basis of pre-test likelihood of CAD: 1. high (> 70%),
2. intermediate (10–70%) and 3. low (< 10%).
Results: Sensitivity and specificity of resting electrocardiography, exercise treadmill
electrocardiography, dobutamine stress echocardiography and created algorithm were calcu-
lated: 23%, 87% and 93%, 21% and 85%, 69% and 96%, 44%, respectively. The prevalence of
CAD in the studied population was 61%.
Conclusions: The diagnostic value of resting electrocardiography in stable CAD is low.
Dobutamine echocardiography has comparable sensitivity but significantly higher specificity
than exercise treadmill test. Our algorithm is simple, reasonably cost-effective and may be
useful in decision making. When the probability of CAD is high, non-invasive testing is not
indicated before coronary angiography; when it is intermediate or low, a first choice test should
be different in female (stress echocardiography) and male (exercise electrocardiography). (Cardiol J
2007; 14: 544–551)
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Introduction
Coronary arteriography is widely accepted as
a gold standard for the diagnosis of coronary artery
disease (CAD) and the evaluation of the extent and
severity of vessel stenoses. Non-invasive diagnos-
tic tests detect the consequences of ischemia: im-
paired cell membrane function, decreased perfusion
and impaired myocardial contractility. None of these
techniques e.g. single-photon emission computed
tomography (SPECT), positron emission tomography
(PET), exercise electrocardiography (ET), stress
echocardiography (DE) and others is perfect [1–3].
Some of these methods are useless since up to 40%
of patients are unfit for adequate exercise [4], some
are expensive and thus discussed in terms of cost-
effectiveness ratio and some patients undergoing
a non-invasive test have an indeterminate result
(indeterminacy rate is up to 40% for exercise elec-
trocardiography and up to 10% for exercise echocar-
diography) [5]. For patients presenting with chest
pain regarded as angina pectoris, estimation of the
probability of the disease is a crucial issue [6]. This
clinical evaluation helps the physician to choose the
optimal non-invasive diagnostic technique, or when
the probability of CAD is high, some clinicians re-
gard coronary angiography as a single reasonable
strategy without prior testing. On the other hand,
the use of coronary angiography routinely as a first-
choice test is not accepted due to the risk of com-
plications and death and its obviously high costs.
On the basis of the remarks above, we decided to
analyse the value of different non-invasive tech-
niques used in CAD diagnosis, to compare them and
to optimize indications for cardiac catheterization.
Many algorithms and nomograms have been creat-
ed for this purpose, but they are time consuming,
complicated, difficult to apply at the patient’s bedside
and often require a computer, so clinicians are scepti-
cal about using them [7–11]. Our goal was to create
a simple diagnostic algorithm useful in clinical prac-
tice for patients complaining of chest pain, and to
estimate its value by comparing cost-effectiveness
with routine non-invasive strategies.
Methods
Materials
Five hundred fifty one patients (49 cases
were excluded from 600 due to lack of full data):
359 men (65%, mean age 51.1 ± 8.9) and 192
women (35%, mean age 53.1 ± 8.9) with chest
pain suspected of CAD were referred by general
practitioners. All enrolled patients subsequently
underwent coronary angiography. Patients with
previous myocardial infarction (Q wave on ECG),
unstable angina, severe heart failure > II NYHA
class, significant valve heart disease, cardiomy-
opathy, uncontrolled hypertension (BP ≥ 200/
/100 mm Hg) and permanent ventricular pacing
were excluded. The characteristics of the study
group are given in Table 1.
Table 1. Characteristics of the study groups.
Coronary artery Coronary artery p
disease (+) (n = 336) disease (–) (n = 215)
Male (n = 359) 268 (80%) 91 (42%) < 0.001
Female (n = 192) 68 (20%) 124 (58%)
Mean age (years) 53.3 ± 8.6 49.6 ± 8.9 < 0.001
Body mass index [kg/m2] 26.5 ± 3.4 25.9 ± 3.1 NS
Cigarette smoking (n = 262) 194 (58%) 68 (32%) < 0.001
Family history of atherosclerosis (n = 222) 143 (43%) 79 (37%) NS
Diabetes (n = 59) 43 (13%) 16 (7%) < 0.05
Hyperlipidemia (n = 295) 197 (59%) 98 (46%) < 0.001
Total cholesterol 236±45 220±41 0.001
LDL cholesterol 159±40 146±65 < 0.05
HDL cholesterol 40±12 45±12 < 0.001
Triglycerides 173±82 161±95 NS
Peripheral or cerebral vascular disease (n = 16) 13 (4%) 3 (1%) < 0.05
Hypertension (n = 298) 189 (56%) 109 (51%) NS
Duodenal or gastric ulcer (n = 74) 41 (12%) 33 (15%) NS
Mitral valve prolapse (n = 30) 9 (3%) 21 (10%) < 0.005
Degenerative spondylopathy (n = 72) 31 (9%) 41 (19%) 0.001
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History
On the basis of history analysis the pre-test
probability of CAD was assessed. For chest pain clas-
sification a special questionnaire was used with three
categories: typical, atypical or nonanginal chest pain
as proposed by Diamond and Forrester [12]. The
likelihood of CAD was estimated on the combina-
tion of age, sex and date of symptoms according to
Diamond and Forrester’s results [12, 13].
Resting electrocardiography
The resting routine electrocardiogram (ECG)
was interpreted by two cardiologists independent-
ly and assigned to one of three categories: normal,
nonspecific abnormalities or typical ischemia pat-
tern [14].
Exercise stress test
Symptom limited treadmill exercise electrocar-
diography was performed with the use of the Bruce
protocol. Classic criteria for test positivity were
used, that is more than 0.1 mV or equal of ST seg-
ment depression from baseline horizontal or down-
sloping at 0.08 seconds from the J point. The pa-
tients taking beta-blocking agents or calcium antag-
onists were instructed to stop medication 72 hours
before the test, but if the treatment was regarded
as necessary by the referring physician it was con-
tinued. The exercise was considered adequate if the
patient achieved 85% of the age-predicted maximal
heart rate. During the exercise test a 12 lead elec-
trocardiogram was monitored continuously. Blood
pressure was measured at baseline and at
1.5-minute intervals during the exercise and for
3 minutes after its termination. The exercise elec-
trocardiography test result was regarded as non-dia-
gnostic if the criterion for electrocardiographic pos-
itivity was not present without obtaining 85% of the
target heart rate [15].
Dobutamine stress echocardiography
Baseline echocardiography and electrocardiog-
raphy were performed. Dobutamine was infused
through a peripheral intravenous line with a me-
chanical pump starting at a dose of 5 µg/kg/min. The
dose was increased every 3 minutes by 5 µg/kg/min.
The end point of the test was the achievement of
the peak dose 40 µg/kg/min, 85% of the target heart
rate. If this rate was not reached, atropine (0.5–1 mg)
was infused. Cross sectional echocardiographic ex-
amination was performed during drug infusion and
up to 10 minutes after the infusion was stopped.
Dobutamine infusion was terminated if any of the
following occurred: target heart rate, new segmental
wall motion abnormalities, complex ventricular
ectopy or sustained supraventricular tachycardia,
hypotension (≥ 20 mm Hg decrease from baseline),
hypertension (systolic BP ≥ 220 mm Hg), severe
chest pain or other intolerable symptoms [16–18].
A 12-lead ECG was recorded at the end of each
5-minute stage and at recovery. The left ventricle
was divided into 16 segments for analysis as rec-
ommended by the American Society of Echocardi-
ography. The ischemia was defined as new or wors-
ening wall motion abnormalities. Dobutamine stress
echocardiography test results were regarded as
non-diagnostic if the target heart rate was lower
than 85%. Patients with an insufficient ‘acoustic’
window were not included in the study.
Coronary angiography
All patients underwent selective coronary an-
giography (CA) by the Judkins technique with mul-
tiple projections. Images were recorded on cine
film. Significant coronary artery disease was defined
as > 50% in a major epicardial artery (in one or
more of the major vessels or in their main branch-
es: diagonal branch of left anterior descending mar-
ginal branch of the left circumflex coronary artery
and posterior descending branch were regarded as
separate vessels) or ≥ 50% in the left main artery.
When an intermedius artery was present, it was con-
sidered equivalent to the major diagonal branch of
left anterior descending [19]. CA was performed
within 8 weeks of non-invasive tests, irrespective of
the obtained results, and was evaluated qualitative-
ly by two independent and experienced physicians.
Statistical analysis
The comparison of pre-test probability of CAD
in the studied population and in Diamond-Forrester’s
group was performed [12]. For correlation, the Pear-
son correlation coefficient was applied (r = 0.85).
The accuracy of non-invasive tests with the use
of coronary angiography as the reference method
was made in the standard way, calculating sensitiv-
ity and specificity according to standard definitions.
Continuous variables were expressed as mean (SD)
and were compared by the Student’s T-test. Qual-
itative variables were expressed as percentages and
were compared with the c2 test. The Fisher test was
used when indicated. Statistical significance was set
at a probability (p) value of < 0.05.
Development of the algorithm
After the calculation of the sensitivity and spe-
cificity of the exercise stress test and dobutamine
echocardiography, on the basis of Bayes theorem
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of conditional probability, the post-test likelihood
of CAD was estimated by using equations given in
the appendix. ET and DE were regarded as inde-
pendent tests and the post-test probability of CAD
calculated from the former became the pre-test like-
lihood for the second test. On the basis of pre-test
variables (age, gender, symptoms-Diamond classi-
fication) and the results of one or two non-invasive
tests, the algorithm was developed by applying
a computer program. The algorithm was modified
to achieve a model of the best sensitivity and ac-
ceptable specificity. Our goal was to make a simple
algorithm applying a combination of clinically relevant
data, not requiring a computer and easy to use for the
physician. The derived algorithm was tested in the
studied population, and the percentage of patients
correctly classified was calculated and compared to
traditional non-invasive testing based on the exercise
stress test and dobutamine echocardiography. In the
proposed algorithm, the pre-test likelihood of CAD
was arbitrarily divided into three groups: low (< 10%),
intermediate (10–70%) and high ≥ 70% [20, 21],
intermediate in men divided into intermediate-high:
30–70% and intermediate-low: 10–29%.
After calculation of the probability of CAD
based on age, gender and chest pain classification,
2% was added for each risk factor in the history and
5% was added for the presence of changes typical
of ischemia in resting ECG in men. This method
was implemented in other studies and was concord-
ant with results of the analysis of the value of rest-
ing ECG in our population [14]. This approach is
based on the assumption that if a given patient has
risk factors typical of CAD, a more aggressive
diagnostic strategy is required.
The study was approved by the National Insti-
tute of Cardiology Ethical Committee on Human
Research in Warsaw. Informed, written consent was
obtained from each patient. The study protocol con-
forms to the ethical guidelines of the 1975 Decla-
ration of Helsinki.
Results
The results of the sensitivity and specificity of
ECG, ET, DE and algorithms are shown in Table 2.
The created algorithms for women and men are
shown in Figure 1. Cost-effectiveness analysis for
five different strategies of CAD diagnosis is pre-
sented in Figure 2. The calculation is based on cost-
data of the Polish National Health Fund (26, 138 and
320 Euro for ET, DE and CA, respectively). Reim-
bursements for these procedures include technical
and professional components.
The strategy called ‘Angio’ assumes the per-
formance of coronary angiography in each patient
suspected of CAD regardless of the other tests and
pre-test probability.
The second and the third strategies, called ET
and DE, make use of only one non-invasive test, i.e.
exercise treadmill electrocardiography or dob-
utamine echocardiography, respectively.
The fourth strategy (DE + ET) is based on the
results of two tests, i.e. DE and ET, performed in-
dependently. Coronary angiography is not per-
formed only if the results of these two tests are
negative. If the results are discordant or positively
concordant, patients undergo coronary angiography.
The fifth strategy, based on the probability
analysis, implements an algorithm derived from our
study. An algorithm, based on probability analysis
and the strategy called ‘angio’ without prior non-
invasive testing, resulted in reasonable cost-effec-
tiveness ratios. The per-test cost of DE exceeds
that of ET, but the total cost of strategy per cor-
rectly diagnosed patient using DE and ET in
Table 2. Comparison of the sensitivity and specificity of electrocardiography (ECG), exercise treadmill
test (ET), dobutamine echocardiography (DE) and algorithm.
Study Sensitivity (%) Specificity (%)
Female Male All patients Female Male All patients
(n = 68)  (n = 268)  (n = 336)  (n = 124)  (n = 91)  (n = 215)
ECG 33 20 23 81 93 87
ET 91 94 93 16 27 21
DE 79 87 85 71 66 69
The algorithm (A) 88 99 96 55 30 44
p — ET vs. DE NS < 0.05 < 0.005 < 0.0001 < 0.0001 < 0.0001
p — A vs. ET NS < 0.05 NS < 0.0001 NS < 0.0001
p — A vs. DE NS < 0.0001 < 0.0001 < 0.05 < 0.001 < 0.0001
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association with pre-test probability (algorithm) is
about the same as the cost of ET strategy with
greater accuracy and less than the cost of DE im-
plemented first. The total cost of this strategy that
implicates DE first is less than the cost of exercise
testing and, subsequently, echocardiography.
Discussion
It is widely accepted and proved in many trials
that non-invasive tests performed for diagnostic
purposes are almost useless in populations with very
high or very low probabilities of the disease [22].
Nevertheless, clinical routine is different. Many
physicians think of non-invasive techniques as good
tools to screen for CAD. Before sending a patient
for ET, for example, one should answer the ques-
tion of whether the management would be changed
by a positive or negative test result. One must keep
in mind data from the CASS [23] showing that with
high probability of CAD in the population, the inci-
dence of false negative results is highest. There-
fore, if the test is negative in a certain patient whose
symptoms are typical of angina, indications for cath-
eterization are obvious. On the other hand, if the
ET test is positive in young women with atypical
chest pain (that is with low probability of CAD), we
know that the proportion of angiography studies
performed in such a situation often reveal normal
coronary arteries [24].
The spectrum of new medical diagnostic
technologies today gives physicians an opportu-
nity to use different tests on one patient [25].
Sometimes results of two or even more tests are
discordant, so the diagnosis is still uncertain, forc-
ing the physician to use a new test or to decide
to use a gold standard method, which in the diag-
nosis of CAD is still angiography. This situation
leads to high expense; the process of diagnosis
is time-consuming and, what is often forgotten,
increases patient anxiety. Our results document
the clinical applicability of the above-mentioned
remarks.
Figure 2. Comparison of different strategies in coronary
artery disease diagnosis based on coronary angiogra-
phy (CA), exercise stress test (ET), dobutamine stress
echocardiography (DE) and the algorithm derived in
the study; FP — false positive, FN — false negative.
Figure 1. Algorithms for coronary artery disease diagnosis. Pre-test probability of coronary artery deisease: H — high,
I — intermediate, L — low, I-H — intermediate-high, I-L — intermediate-low. Diagnostic tests: DE — dobutamine
stress echocardiography, ET — exercise stress test, + positive test result, – negative test result, ndg — non-
-diagnostic test result.
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Sensitivity of ET in our study is concordant
with mean values found in the biggest meta-analy-
ses, but the specificity is surprisingly low (85% of
women with positive ST response had normal cor-
onary arteries) [1]. This gave us the idea that the
diagnostic CAD strategy in women based on exer-
cise testing as a first-choice test leads to worse
results. High sensitivity and very low specificity of
ET can be explained by the fact that patients with
previously positive tests are more frequently re-
ferred for catheterization. The studied population
probably reflects post-test referral bias, because we
do not know if the ET performed in this study was
the first in the patient’s lifetime [15]. Of course,
patients with heart disease other than CAD, which
might predispose them to false positive results,
were excluded, but subclinical ventricular hypertro-
phy due to treated hypertension might also be the
reason for the low specificity of ET. Using differ-
ent criteria for positive ET (i.e. more than 1 mm
ST depression), an investigator can get greater spe-
cificity and slightly lower sensitivity. Several cur-
rently available tests for non-invasive diagnosis of
CAD are more accurate than traditional exercise
electrocardiography, i.e. SPECT or PET, but they
are also more expensive and thus their clinical use
is limited.
Sensitivity and specificity of DE are satisfac-
tory and concordant with different publications [26].
Values obtained for these two techniques (DE and
ET) are typical of the clinical practice in our coun-
try; they are based on the biggest prospective trial
in this field in Poland. Echocardiography is more
physician dependent; nevertheless, it possesses
higher sensitivity and specificity. A unique feature
of DE is the detection of forms of heart disease oth-
er than CAD associated with chest pain (hyper-
trophic cardiomyopathy, mitral valve prolapse).
This method is even superior to angiography for the
prediction of subsequent cardiac events [18].
Dobutamine echocardiography is two times
more expensive than ET, so it should be reserved
for cases difficult to diagnose [27]. We decided to
use it for women and only for those men in whom
the probability of CAD is < 70% (intermediate or
low), while ET is good enough as a first-choice test
in men.
Our algorithm is characterised very good sen-
sitivity and acceptable specificity. In patient sub-
groups with a high probability of CAD, we found
coronary angiography without previous non-inva-
sive testing successful in terms of the correctness
of the diagnosis and reasonably cost-effective. This
is a lower cost testing strategy than the algorithm
but the cost difference is negligible. The applica-
tion of our scheme reduces the amount of angiog-
raphies by 19%. We propose to use the non-inva-
sive diagnostic testing in cases of a moderate risk
of CAD (when the probability is intermediate or
low). A first-choice test should be different in wom-
en-DE and men-ET. Detection of CAD in women
is more difficult due to lower prevalence of the dis-
ease in the population at the same age. In addition,
chest pain symptomatology differs between wom-
en and men. So the pre-test probability of CAD
should be considered first [28, 29]. Guidelines for
the management of patients with CAD suspicion
stratify the probability of disease into three groups,
i.e. low, intermediate and high. Within the litera-
ture are found numerous models; the cut-off points
between probability groups are drawn arbitrarily
[20, 21].
Dobutamine echocardiography and the derived
algorithm have been shown to be superior to exer-
cise electrocardiography in diagnostic performance
[30–33]. An important limitation of this study is the
relatively small number of women in comparison
with that of men. We analysed 12 false negative
cases for CAD diagnosis after application of the al-
gorithm. Even if the result was false-negative, the
extent of jeopardized myocardium was relatively
small (angiography revealed small coronary branch
stenosis, or significant stenosis was present in the
distal part of the major artery).
We welcome future evaluation of the proposed
algorithm in different populations.
Appendix
The probability of coronary artery disease in
a patient with a positive test was calculated by the
equation:
The probability of coronary artery disease in
a patient with a negative test was calculated by the
equation:
Sensitivity × Prevalence
(Sensitivity × Prevalence) +
+ (1 – Specificity) × (1 – Prevalence)
P (CAD/T+) =
P (CAD/T–) =
(1 – Sensitivity) × Prevalence
(1 – Sensitivity) × Prevalence +
+ Specificity × (1 – Prevalence)
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